Hematology/Oncology

Top Story

Coffee may improve survival in colon cancer

Coffee may improve survival in colon cancer
December 13, 2017

Patients with colorectal cancer who drank coffee, either caffeinated or decaffeinated, showed a lower risk for colorectal cancer-specific death and overall death in two large prospective cohort studies.

The benefits were strongest in patients who drank at least two cups per day both before and after their diagnosis.

Meeting News

Transplant-associated thrombotic microangiopathy may be ‘final pathway’ of other disorders

December 13, 2017
ATLANTA — Transplant-associated thrombotic microangiopathy may be a final common pathway for several disorders with different pathophysiologic mechanisms…
Meeting NewsPerspective

CAR T-cell therapy bb2121 shows promising efficacy for multiple myeloma

December 13, 2017
ATLANTA — Anti-B-cell maturation antigen chimeric antigen receptor T-cell therapy bb2121 showed 94% overall response rates at high dose levels, according to…

AMA: 4 out of 5 US physicians are cyberattack victims

December 12, 2017
Slightly more than 80% of U.S. physicians have experienced a type of cybersecurity attack, with the most common being phishing and computer viruses, according to a new…

Net neutrality repeal may diminish telemedicine access, harm small practices

December 12, 2017
A repeal of net neutrality as proposed by the Federal Communications Commission could lead to unintended and devastating consequences for physicians in small practices…
More Headlines »
CME ABIM MOC

Ace the Case: A 54-Year-Old Man With Intermittent, Painless Hematuria for the Past 4 Weeks

There is no commercial support for this activity.

This “Ace the Case” study will discuss the treatment of a 54-year-old man who presents with intermittent…
More »
Video
Meeting News

VIDEO: Geographic location plays role in renal cell carcinoma outcomes

November 3, 2017
More »
Resource Centers
San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium

CME

Expert Update: What's New in Essential Thrombocythemia

This activity is supported by an educational grant from Incyte Corporation.

Appropriate early diagnosis and initiation of therapy is essential in the management of myeloproliferative neoplasms…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement